Verition Fund Management
VINC

Verition Fund Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Verition Fund Management’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,520
Closed -$973K – 2199
2021
Q1 		$973K Buy
+2,520
New +$1.02M 0.01% 619

Other funds holding VINC

SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Verition Fund Management's VINC Position: Q2 2021 in Review

Verition Fund Management sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2021, closing a stake of 2,520 shares — an estimated $973K sold.

Verition Fund Management first reported a position in VINC in Q1 2021 and held it in 1 quarter. The position peaked at $973K in Q1 2021. 56 funds tracked by Wall St. Rank hold VINC as of Q2 2021.

  • Verition Fund Management reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Verition Fund Management sold 2,520 Vincerx Pharma, Inc. Common Stock shares in Q2 2021, an estimated $973K.
  • Verition Fund Management first reported a position in Vincerx Pharma, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Verition Fund Management's Vincerx Pharma, Inc. Common Stock position peaked at $973K in Q1 2021.
  • 56 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2021.

Based on Verition Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.